Aparkin 50 mg+12.5 mg

Aparkin 50 mg+12.5 mg — Levodopa + Benserazide উপাদানসমৃদ্ধ ক্যাপসুল। প্রস্তুতকারক: Ziska Pharmaceuticals Ltd.।

This immediate release capsule is indicated for the treatment of all forms of Parkinson's syndrome with the exception of medicine-induced Parkinsonism. On the other hand, controlled release capsule indicated for patients presenting with all types of motor fluctuations in response, especially those related to fluctuations in plasma levels (i.e. "peak dose dyskinesia" and "end of dose deterioration") and for better control of nocturnal symptoms.